AI Investors in Cambridge (2026): Who Is Backing Early-Stage Startups
The funds backing early-stage AI startups in Cambridge in 2026, from pre-seed to Series A, with cheque sizes, recent deals and where to start.

Investors backing early-stage AI startups in Cambridge in 2026 include Cambridge Innovation Capital, Cambridge Enterprise Ventures, Parkwalk Advisors, Twin Path Ventures, Amadeus Capital Partners and IQ Capital, from pre-seed to Series A.
Researched and written by Zeeshan Ali at Platvix. Checked on 21 October 2026.
TL;DR
- Who writes the first cheque in Cambridge? Cambridge Enterprise Ventures backs University of Cambridge spinouts and recorded 28 pre-seed investments in 2023-24, Twin Path Ventures led a Cambridge AI pre-seed round in September 2025, and IQ Capital says it leads rounds from pre-seed upwards.
- Do I have to be a university spinout? Several of these funds have mandates tied to University of Cambridge research, including Cambridge Innovation Capital's £250 million Fund III and its commitment of at least £100 million to University of Cambridge spinouts. Twin Path and IQ Capital lead from pre-seed, and Amadeus invests from seed upwards.
- What size cheques are realistic? Twin Path writes £300k to £1m, and the University's START programme puts in £30,000 on acceptance and takes no equity until you raise from other investors.
Early-stage AI investors in Cambridge
Cambridge Innovation Capital
A deep tech and life sciences investor built around the Cambridge cluster, backing companies from inception through to early-stage growth.
- Invests in: deep tech and life sciences founders, with Fund III described as a £250 million early-stage venture fund focused on the Cambridge ecosystem
- AI startups backed: Sortera Bio, whose Deep Screening platform generates machine learning datasets for generative AI models, and Trent AI, which builds security agents for autonomous systems
- Latest deal: took part in the first close of a £36m Series C for Microbiotica, announced on 16 October 2026 and led by the British Business Bank. Microbiotica sits at Chesterford Research Park in Little Chesterford, Essex, just outside Cambridge. CIC's most recent deal inside Cambridge is TRIMTECH Therapeutics' additional $14m seed investment on 23 June 2026, a follow-on it joined as an existing investor, led by JJDC, Johnson & Johnson's corporate venture capital organisation, and BGF
- Latest fund: on 1 August 2025 CIC committed at least £100 million to University of Cambridge spinouts
- Website: cic.vc
Cambridge Enterprise Ventures
The University of Cambridge's own investor, putting University capital into Cambridge spinouts and startups.
- Invests in: Cambridge spinouts and startups. Cambridge Enterprise says it "invests University of Cambridge capital into high impact, high growth Cambridge spinouts and startups" and records 28 pre-seed investments in 2023-24
- AI startups backed: Trismik, which tests large language models for accuracy, bias and toxicity
- Latest deal: backed Neela Biotech's £2.1m pre-seed round, announced on 8 October 2026 and led by Elbow Beach with £1.5m, with Cambridge Enterprise Ventures, Ascension, Ventures Together and strategic angel investors making up the rest of the round. Neela Biotech is Cambridge-based and turns food, agricultural and forestry waste into sustainable aviation fuel through what the announcement calls an AI-guided, controlled microbial process
- Latest led round: led xWatts' £1.6m seed round on 10 February 2026, with Cambridge Angels, Parkwalk and R42 joining. xWatts is London-based and runs an AI-driven energy management platform for commercial buildings
- Latest fund: on 1 August 2025 the University added £30m of new capital to the £100m Cambridge Enterprise Ventures fund
- Website: enterprise.cam.ac.uk
Parkwalk Advisors
An EIS manager that runs university spinout funds, including a Cambridge-dedicated series managed with Cambridge Enterprise.
- Invests in: university spinouts, with the University of Cambridge Enterprise Funds giving investors exposure to companies based on Cambridge research at seed to Series A, with EIS tax reliefs available
- AI startups backed: Trismik, an AI evaluation company, and xWatts
- Latest Cambridge deal: joined the £1.6m round for Cambridge protein company Qkine announced on 2 September 2026, a follow-on alongside CPI Enterprises, EverQuest Capital Partners and EMV Capital
- Website: parkwalk.vc
Twin Path Ventures
An AI-first fund that invests at the earliest stage across the UK and led a Cambridge pre-seed round in 2025.
- Invests in: AI-first startups, backing up to 15 companies a year
- Cheque size: £300k to £1m
- AI startups backed: Trismik, plus AI companies including Sention, Amply Discovery and Composo AI
- Latest Cambridge deal: led Trismik's £2.2m pre-seed round, announced on 24 September 2025, with Cambridge Enterprise Ventures, Parkwalk Advisors, Fund F, Vento Ventures and angels from Ventures Together
- Latest fund: British Business Investments committed £10 million over three years on 20 February 2025
- Website: twinpath.vc
Amadeus Capital Partners
A deep tech investor backing AI, machine learning, computing and quantum companies from seed upwards.
- Invests in: founders "advancing AI, machine learning, computing, and quantum technologies", "from seed to growth across three technology areas"
- AI startups backed: Refute, an AI-powered counter disinformation company
- Latest Cambridge deal: took part in Nu Quantum's $60m Series A on 10 December 2025 as an existing investor, a follow-on. Nu Quantum is based in Cambridge and Los Angeles
- Latest deal: took part in iPronics' $125m Series B announced on 2 September 2026, co-led by Maverick Silicon and Light Street Capital. iPronics works on silicon photonics for AI infrastructure and is based in Valencia and Santa Clara
- Website: amadeuscapital.com
IQ Capital
A deep tech fund that leads rounds from pre-seed to Series A and follows on into later rounds.
- Invests in: deep tech founders. IQ Capital says it "lead[s] rounds at pre-Seed to Series A and with our growth opportunity funds can follow-on with up to $40m"
- AI startups backed: Mindgard, an AI security company, RevEng.AI, which verifies AI-generated software, and Undecimal Bio, whose DELiveri platform uses agentic AI to read structure-activity data and pick out molecules that can carry siRNA into target cells
- Latest deal: co-led Undecimal Bio's $18m seed round with 4BIO Capital, announced in October 2026, with Verve Ventures, Harel Tech, Entree Capital, Kerna Ventures and Saras Capital also taking part. Undecimal Bio has laboratories at the Cancer Research UK Cambridge Institute and was carved out of Eleven Therapeutics
- Website: iqcapital.vc
Also worth knowing
Cambridge Angels says it has been investing since 2001 and has supported more than 150 companies, with membership capped at 65 and mostly made up of exited entrepreneurs in tech and healthcare. It joined xWatts' £1.6m seed round in February 2026. o2h ventures sits at The Mill SciTech Park in Hauxton, Cambridge, and runs SEIS and EIS funds for biotech therapeutics and the intersection of biotech with machine learning. EMV Capital also took part in the Qkine round in September 2026.
Other support in the region
START 3.0, run by Founders at the University of Cambridge, calls itself a pre-seed programme for AI and DeepTech startups connected to the University. It invests £30,000 on acceptance, up to £70,000 more in matched investment if you raise externally, and up to £500,000 to pitch for, and it takes no equity until you raise from other investors, at which point its SAFE converts. Applications for START 3.0 closed on 17 December 2025, and the cohort of eight companies finished with a showcase in London on 12 October 2026, so check the programme page for the next intake. Accelerate Cambridge at Cambridge Judge Business School runs a 12-week venture development programme with a dedicated coach and access to investors. On 16 April 2026, ET Capital launched the Cambridge Venture Index SEIS/EIS Fund 2, which plans to back up to 20 early-stage science-based companies from the Cambridge and Oxford ecosystems.
FAQ
Which of these investors backs AI and nothing else?
Twin Path Ventures. It describes itself as backing AI-first startups and says it has been investing in AI since 2014. The others are deep tech and life sciences investors that back AI alongside quantum, semiconductors and therapeutics.
I am a University of Cambridge spinout raising pre-seed. Where should I start?
Cambridge Enterprise Ventures invests University of Cambridge capital into Cambridge spinouts and startups and recorded 28 pre-seed investments in 2023-24. START is open to founders with a University affiliation in the last five years, and applications for the START 3.0 intake closed in December 2025, so watch for the next one. Parkwalk's University of Cambridge Enterprise Funds, run with Cambridge Enterprise, back companies based on Cambridge research at seed to Series A.
How were these investors chosen?
Each one invests at pre-seed, seed or Series A, has a stated AI focus or a dated AI deal, has made a new investment in the last 18 months, and has either a Cambridge fund mandate or a dated Cambridge investment in the last 24 months.
How do I find which Cambridge investors fit my startup?
Platvix is an investment intelligence platform for founders. It helps you through your fundraising journey, from analysing your pitch deck to finding the right capital for your startup, including VC firms, angels, accelerators and grants.
Where to go from here
- AI Investors in London
- AI Investors in Manchester
- AI Investors in Edinburgh
- AI Investors in Leeds and Yorkshire
- AI Investors in the North East
- What investors look for in AI startups
- How investors fact-check the claims in your AI deck
Find the Cambridge investors most likely to back you
Work out which of these funds fits your stage, sector and route to market before you start sending your deck.
Start your investor research →
If you run one of these funds and something has changed, get in touch.
Tags
- Investors
- AI Startups
- UK Fundraising
- Pre-seed
- venture-capital
- SEIS
About the author
Zeeshan Ali, Co-Founder
Co-founder at Platvix, building an investment intelligence platform and the ecosystem around it so founders become investment-ready faster and VCs make stronger decisions. I focus on operations, partnerships, and community building, turning strategy into execution through programmes, processes, and founder support.